Tonix Pharmaceuticals Holding Corp.
General ticker "TNXP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $68.1M (TTM average)
Tonix Pharmaceuticals Holding Corp. follows the US Stock Market performance with the rate: 11.6%.
Estimated limits based on current volatility of 6.4%: low 15.97$, high 18.17$
Factors to consider:
- Total employees count: 81 (-21.4%) as of 2024
- Top business risk factors: Cybersecurity threats, Operating losses, Regulatory and compliance, Insufficient funding, Commercialization challenges
Short-term TNXP quotes
Long-term TNXP plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $7.77MM | $10.09MM |
| Operating Expenses | $112.09MM | $126.15MM | $146.79MM |
| Operating Income | $-112.09MM | $-118.38MM | $-136.70MM |
| Non-Operating Income | $1.87MM | $0.00MM | $6.15MM |
| R&D Expense | $81.88MM | $86.66MM | $39.97MM |
| Income(Loss) | $-110.22MM | $-118.38MM | $-130.55MM |
| Profit(Loss)* | $-110.22MM | $-118.38MM | $-130.55MM |
| Stockholders Equity | $207.18MM | $105.53MM | $139.56MM |
| Inventory | $0.00MM | $14.15MM | $8.41MM |
| Assets | $225.69MM | $154.46MM | $162.89MM |
| Operating Cash Flow | $-98.05MM | $-102.00MM | $-60.92MM |
| Capital expenditure | $48.15MM | $7.89MM | $0.12MM |
| Investing Cash Flow | $-48.15MM | $-29.07MM | $-0.12MM |
| Financing Cash Flow | $87.84MM | $36.52MM | $134.87MM |
| Earnings Per Share** | $-35.91 | $-64.63 | $-57.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.